Endothelial cell effects on GBM cell growth were blocked by both the specific CXCR4 antagonist AMD3100 and knock-down of endothelial cell CXCL12 expression with short hairpin interfering RNA (shRNA). The gene discussed is CXCL12; the disease is glioblastoma.